Of 1300 epileptic patients 76 (5.8%) were found to have juvenile myoclonic epilepsy (JME). These 76 patients were examined at the epilepsy outpatient clinic of Bakirkoy State Hospital for Neurological and Psychiatric Diseases between 1991 and 1996 and data obtained were analysed retrospectively. Clinically typical absence seizures were reported in 40.8%, myoclonic jerks in lOO%, and generalized tonic<lonic seizures in 82.9% of the patients. Neurological and mental examination was normal for all patients with the exception of three cases; two with essential tremor and one with minimal dysarthria. Precipitating factors were noted in 85.5% of cases. Abnormal EEG was recorded in 73 (6.1%) patients. Abnormalities mainly consisted of generalized discharges of spike/polyspike and slow-wave (86.6%) and generalized paroxysmal theta or delta (9.2%). Fifteen (19.7%) had focal abnormalities and 20 (26.4%) had photoconvulsive discharges. Of the 76 patients, 40 (52.6%) were not diagnosed at the initial interview; definite diagnosis was delayed by a mean of 5.9 years. As a result of misdiagnosis at the initial interview 40 patients had been administered AED except for valproate. After reassessment of clinical and EEG findings, the medication was changed to valproate therapy. As a result, 65 of our JME patients (85.5%) were seizure free after a one-year follow-up period.
INTRODUCTION
Juvenile myoclonic epilepsy (JME) is a generalized idiopathic epileptic syndrome with age-related onset and a prevalence of 5-l 1% amongst other forms of epilepsy. The following features distinguish the disease from other seizure disorders; (1) typical absence seizures (AS), myoclonic jerks (MJ), and generalized tonic-clonic seizures (GTCS) in a consistent age-related sequence; (2) circadian distribution and characteristic seizure-precipitating factors; (3) normal physical examination and CT brain scan; (4) characteristic EEG with generalized 4-6 Hz spike/multiple spike and slow waves; (5) family history of epilepsy; (6) complete remission of seizures in 80% of patients treated with appropriate anticonvulsants"'.
Despite these certain diagnostic criteria, JME is still misdiagnosed by physicians and even experienced neurologists . 1-4 We investigated our cases retrospectively to assess the pitfalls in JME diagnosis.
METHODS

AND PATIENTS
Data from 76 (27 female, 49 male) patients with JME examined at the epilepsy outpatient clinic of Bakirkiiy State Hospital for Neurological and Psychiatric Diseases between 1991 and 1996 were analysed retrospectively. All patients had well-documented diagnoses of JME, based on both clinical and EEG findings (according to previously published diagnostic criteria by Panayiotopoulos et al 1989)5. Patients were evaluated according to the following features; (a) demographic and clinical data (prevalence, type of seizures and age at onset, precipitating factors, family history of epilepsy, neurological and mental examination, initial diagnosis, age at correct diagnosis, duration, and causes of delay in diagnosis), (b) EEG findings, (c) neuroimaging findings, (d) initial treatment, (e) response to treatment. EEG examinations were performed using a 16-channel Medelec 1118 device. We obtained conven-tional EEG recordings from all patients along with activating methods. The patients with normal EEG findings were invited for a second EEG evaluation after 24-hour sleep deprivation (n = 28). The AED therapy that patients had already been taking was continued.
RESULTS
Of 1300 patients with epilepsy 76 (5.8%) were found to have JME. All 76 patients were found to have myoclonic jerks (MJ). Thirty one (40.8%) also had typical absence seizures (AS) and 63 (82.9%) had generalized tonic-clonic seizures (GTCS). Five (6.6%) of our patients only had MJ, 40 had GTCS and MJ (52.6%), eight had AS and MJ (lOS%), and 23 had MJ, AS and GTCS (30.3%). The age of onset ranged from 11 to 23 years (mean: 12.5 f2.12 years) with AS, MJ and GTCS beginning at a mean age of 12.53f4.49 (3-23), 15.09f2.47 (9-23), 15.42f3.17 (8-23) years, respectively.
Precipitating factors were detected in 65 (85.5%) patients. These were, in order of frequency, sleep deprivation (85.5%), photic stimulation (25%), stress (18.4%), fatigue (11.8%), and menstruation (2.6%).
A reliable family history of epilepsy was obtained in 33 (43.4%) patients. First-or second-degree relatives with JME were noted in seven (9.2%) patients. These members were a parent, an uncle, two siblings, two cousins and a nephew. Three of them expand mild absences whereas four of them were diagnosed on both clinical and EEG grounds, three only on a clinical basis. Consanguinity was noted in 22 (28.9%) patients' parents. Only two of seven relatives diagnosed as JME were amongst families with consanguinity marriages.
Neurological and mental examination was normal in all patients, except for two essential tremor and one minimal dysarthria cases. Except for three EEG recordings showing an excess of theta activity, background activity was normal in all patients.
All of the CT (n = 33) and MRI (n = 3) investigations of the patients were normal. Of the 76 patients, 40 (52.6%) were misdiagnosed at the initial evaluation. The most common misdiagnosis was GTCS (n = 28), followed by complex partial seizures (n = 11) and simple partial seizures (n = 1). Mean age at the correct diagnosis was 22.5 f3.5 years (12-38 years). Definite diagnosis was delayed by a mean of 5.9 years (from 6 months to 14 years).
All of the misdiagnosed cases were previously evaluated by neurologists or physicians in different centres. The factors responsible for the delayed diagnosis were multiple. Of the 40 misdiagnosed patients, 28 were not questioned about myoclonic jerks. In 18 of 28 patients EEG was not appreciated despite typical generalized spike/polyspike and slow-wave abnormalities. Twelve patients with focal EEG abnormalities were misdiagnosed as having complex partial seizures (n = 11) and simple partial seizures (n = 1) with secondary generalization. As a result of misdiagnosis at the initial evaluation, 40 patients had been administered various AEDs except for VPA. It was found that CBZ and PHT exacerbated myoclonic jerks in 16 and four patients, respectively. Moreover, CBZ induced absences in four patients and polytherapy with CBZ, PHT and PB aggravated the frequency of myoclonic jerks in eight patients.
After reassessment of clinical and EEG findings, the medication of the misdiagnosed group were changed to VPA therapy (Table 3 ) and 65 patients (85.5%-including 35 of misdiagnosed group) were seizure free after a follow-up period ranging from 1 to 11 years. The remaining 11 patients showed a remarkable improvement (Table 4) . We did not try to discontinue the therapy even after a long seizure-free period.
DISCUSSION
We have demonstrated that JME is a common epileptic syndrome in our country (5.8%). It is similar to the prevalence of JME (5-l 1%) reported in various studies'*",c9.
In addition to MJ, more than 80% of JME patients presented with GTCS after awakening6,7, 'n. The other seizure type which may be associated with JME is absence, accounting for approximately IO-40% of cases',6q7. In our study GTCS was found in 82.9% and AS in 40.8% of our patients.
Mean age at onset of MJ and GTCS in our study is consistent with the previous reports. On the other hand, mean age at onset of AS was found to be slightly higher in our group"3.6.7,9-'3.
The most common seizure-precipitating factors in this study were sleep deprivation, photic stimulation, stress, fatigue and menstruation. Alcohol was not found to be an important precipitating factor probably because of its limited consumption in our country.
Genetic factors are clearly of aetiological importance. We found a high family history of epilepsy (43.4%) and consanguinity (28.8%) as reported in previous studies. It is similar to the rates reported by Penryt" (36%), Grtinewald' (33.3%) Clement" (50%) and Panayiotopoulos4 (48.7%, Saudi Arabia). Consanguinity in our patients' families was lower than Panayiotopoulos' study4 (43.9%, Saudi Arabia). Despite well-defined clinical and EEG features, JME remains underestimated by physicians'. Misdiagnosis of JME has been emphasized by Janz7, Asconapel' (8.5 years), Grtlnewald' (14.5 years), Panayiotopou10s~ (8.3 years). Comparisons of delay in diagnosis between these studies and our's (5.9 years) show that the diagnostic yield improved with heightened medical awareness. The factors responsible for the delayed diagnosis of JME in our study were often multiple. In many cases the seizure history was inadequate, such as patients not being questioned about MJ. Most of the patients did not complain of myoclonic jerks and these were revealed only by questioning. In some cases physicians seemed to be unaware of the syndrome. Another factor in misdiagnosis may be presence of atypical EEG findings. The characteristic finding is a paroxysmal, generalized, symmetric polyspike and slow-wave discharge. Focal abnormalities were found in 15 (19.7%), and apparent asymmetry in magnitude of generalized discharges in 38 (50%) patients. Our focal abnormality rate was lower than Panayiotopoulos" (30.3%), Alibertis (54.5%) and Grtinewald' (33%) studies. Clinical and EEG asymmetries in JME patients are frequent causes of misdiagnosis' ' . LancmanJ4 noted asymmetries in 30.6% of his patients; 16.5% had clinical and 16.5% EEG asymmetries. But, he evaluated unilateral polyspike and slow-wave discharges together with asymmetries in voltage and found EEG asymmetries in 16.5% of his patients.
The typical and patognomonic epileptic discharges were found in 86.6% of cases. Twenty patients (26.4%) had photosensitivity. These results are similar to previous reports],".
Treatment with VPA is effective for JME. Although AED therapy with phenytoin, pirimidone, phenobarbital or even carbamazepine would control some of the seizure components of JME, it may also cause aggravation of seizures or even addition of new seizure types. In our study, as a result of misdiagnosis at the initial assessment. 40 patients had been administered various AEDs except for VPA. In the misdiagnosed group, CBZ exacerbated MJ in 16 patients and phenytoin in four patients, while polytherapy with CBZ-PHT or CBZ-PB aggravated the frequency of MJ in eight patients. Moreover. CBZ induced AS in four patients. Valproate is the only available AED has been shown to be effective in controlling the seizure components of JME without significant side effects. The significance of the correct diagnosis was reflected in response to treatment. Sixtyfive patients (85.5%) were seizure free for at least 1 year, while 11 (14.4%) patients showed remarkable improvement and of those patients 68 (89%) were receiving valproate monotherapy. These results are similar to Penry's study'".
In conclusion, despite the high rate of consanguineous marriages. the prevalence of JME is lower in our study, which may be related to ongoing misdiagnosis. On the other hand, the relatively shorter time we needed to establish the correct diagnosis indicates that having knowledge and experience in this area as well as obtaining adequate history from the patient would increase the rate of correct diagnosis and prevalence in the near future.
